6O39 | Signaling Protein | date | Feb 26, 2019 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Crystal Structure Of Frizzled 5 Crd In Complex With F2.I Fab | ||||||||||||||
authors | S.Raman, M.Beilschmidt, J.Fransson, J.P.Julien | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Antibody F2.I Fab, Light Chain Chain: A Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_taxid: 9606 Expression_system: Homo Sapiens Expression_system_taxid: 9606 | ||||||||||||||
Molecule: Antibody F2.I Fab, Heavy Chain Chain: B Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_taxid: 9606 Expression_system: Homo Sapiens Expression_system_taxid: 9606 | ||||||||||||||
Molecule: Frizzled-5 Chain: C Synonym: Hfz5,Fze5 Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Fzd5, C2orf31 Expression_system: Homo Sapiens Expression_system_taxid: 9606 | ||||||||||||||
symmetry | Space Group: P 61 2 2 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.80 Å | ||||||||||||
ligand | ACT, EDO, NAG | enzyme |
| ||||||||||||
Primary reference | Structure-guided design fine-tunes pharmacokinetics, tolerability, and antitumor profile of multispecific frizzled antibodies., Raman S, Beilschmidt M, To M, Lin K, Lui F, Jmeian Y, Ng M, Fernandez M, Fu Y, Mascall K, Duque A, Wang X, Pan G, Angers S, Moffat J, Sidhu SS, Magram J, Sinclair AM, Fransson J, Julien JP, Proc Natl Acad Sci U S A. 2019 Mar 20. pii: 1817246116. doi:, 10.1073/pnas.1817246116. PMID:30894493 |
Data retrieval |
View 6O39 in 3D |
Visual 3D analysis of 6O39 |
Structure-derived information |
Sequence-derived information |
Other resources with information on 6O39 |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |